This article {extract} was published in Communicable Diseases Intelligence Vol 29 No 1 March 2005 and may be downloaded as a full version PDF from the Table of contents page.
Results
Summary of 2002 data
There were 100,278 communicable disease notifications received by NNDSS in 2002 (Table 2). Notification rates per 100,000 population for each disease by state or territory are shown in Table 3. Trends in notifications and rates per 100,000 population for the period 1998 to 2002 are shown in Table 4.
Table 2. Notifications of communicable diseases, Australia, 2002, by state or territory
Disease |
State or territory | Aust | |||||||
|---|---|---|---|---|---|---|---|---|---|
| ACT | NSW | NT | Qld | SA | Tas | Vic | WA | ||
Bloodborne diseases |
|||||||||
| Hepatitis B (incident) | 0 |
84 |
10 |
54 |
11 |
19 |
175 |
35 |
390 |
| Hepatitis B (unspecified)†,‡ | 82 |
3,492 |
NN |
742 |
267 |
40 |
1,891 |
402 |
6,916 |
| Hepatitis C (incident) | 6 |
149 |
NN |
NN |
42 |
15 |
87 |
135 |
434 |
| Hepatitis C (unspecified)†,‡,§ | 226 |
6,675 |
193 |
2,699 |
641 |
381 |
4,092 |
1,074 |
15,981 |
| Hepatitis D | 0 |
10 |
0 |
1 |
0 |
0 |
9 |
0 |
20 |
| Hepatitis (NEC) | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Gastrointestinal diseases |
|||||||||
| Botulism | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Campylobacteriosis║ | 356 |
NN |
208 |
3,885 |
2,441 |
606 |
5,020 |
2,089 |
14,605 |
| Cryptosporidiosis | 36 |
303 |
217 |
2,026 |
121 |
47 |
290 |
215 |
3,255 |
| Haemolytic uraemic syndrome | 0 |
7 |
1 |
1 |
0 |
0 |
4 |
0 |
13 |
| Hepatitis A | 4 |
146 |
47 |
68 |
15 |
4 |
74 |
30 |
388 |
| Hepatitis E | 1 |
6 |
0 |
1 |
0 |
2 |
2 |
0 |
12 |
| Listeriosis | 0 |
11 |
0 |
20 |
2 |
2 |
13 |
11 |
59 |
| Salmonellosis (NEC) | 92 |
2,036 |
330 |
2,673 |
504 |
165 |
1,251 |
705 |
7,756 |
| Shigellosis | 0 |
83 |
103 |
93 |
25 |
1 |
67 |
124 |
496 |
| SLTEC, VTEC¶ | 0 |
0 |
0 |
5 |
37 |
0 |
5 |
4 |
51 |
| Typhoid | 1 |
24 |
0 |
12 |
4 |
0 |
22 |
10 |
73 |
Quarantinable diseases |
|||||||||
| Cholera | 0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
| Plague | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Rabies | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Viral haemorrhagic fever | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Yellow fever | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Sexually transmissible diseases |
|||||||||
| Chlamydial infection (NEC) | 460 |
5,527 |
1,451 |
6,449 |
1,741 |
478 |
4,972 |
2,961 |
24,039 |
| Donovanosis | 0 |
0 |
9 |
5 |
0 |
0 |
0 |
2 |
16 |
| Gonococcal infection** | 15 |
1,400 |
1,530 |
935 |
192 |
14 |
820 |
1,341 |
6,247 |
| Syphilis†† | 12 |
625 |
414 |
341 |
31 |
16 |
27 |
161 |
1,627 |
Vaccine preventable diseases |
|||||||||
| Diphtheria | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Haemophilus influenzae type b | 0 |
10 |
3 |
6 |
2 |
0 |
2 |
6 |
29 |
| Invasive pneumococcal disease | 30 |
841 |
65 |
437 |
174 |
63 |
454 |
207 |
2,271 |
| Laboratory-confirmed influenza | 19 |
1,002 |
56 |
1,153 |
289 |
5 |
598 |
543 |
3,665 |
| Measles | 0 |
8 |
0 |
8 |
1 |
0 |
14 |
0 |
31 |
| Mumps | 0 |
29 |
1 |
6 |
10 |
0 |
10 |
13 |
69 |
| Pertussis | 50 |
1,863 |
37 |
1,852 |
453 |
41 |
884 |
208 |
5,388 |
| Poliomyelitis | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Rubella‡‡ | 3 |
35 |
1 |
190 |
5 |
1 |
16 |
4 |
255 |
| Tetanus | 0 |
0 |
0 |
2 |
0 |
0 |
0 |
1 |
3 |
Vectorborne diseases |
|||||||||
| Arbovirus infection NEC | 0 |
15 |
0 |
5 |
0 |
0 |
2 |
0 |
22 |
| Barmah Forest virus infection | 0 |
389 |
23 |
388 |
3 |
0 |
57 |
36 |
896 |
| Dengue | 3 |
66 |
32 |
81 |
7 |
1 |
11 |
18 |
219 |
| Japanese encephalitis | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Kunjin virus infection | NN |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Malaria | 13 |
104 |
24 |
205 |
14 |
16 |
64 |
26 |
466 |
| Murray Valley encephalitis | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
| Ross River virus infection | 0 |
178 |
63 |
887 |
41 |
117 |
38 |
123 |
1,447 |
Zoonoses |
|||||||||
| Anthrax | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Australian bat lyssavirus | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Brucellosis | 0 |
2 |
0 |
35 |
0 |
0 |
2 |
1 |
40 |
| Leptospirosis | 0 |
36 |
3 |
91 |
2 |
2 |
18 |
3 |
155 |
| Ornithosis | 0 |
143 |
2 |
3 |
3 |
1 |
42 |
5 |
199 |
| Other lyssavirus (NEC) | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Q fever | 0 |
292 |
1 |
339 |
27 |
0 |
83 |
19 |
761 |
Other bacterial infections |
|||||||||
| Invasive meningococcal infection | 6 |
213 |
9 |
123 |
31 |
26 |
210 |
66 |
684 |
| Legionellosis | 3 |
42 |
1 |
44 |
66 |
0 |
107 |
55 |
318 |
| Leprosy | 0 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
3 |
| Tuberculosis | 15 |
433 |
38 |
122 |
39 |
10 |
270 |
48 |
975 |
| Total | 1,433 |
26,280 |
4,873 |
25,991 |
7,241 |
2,073 |
21,705 |
10,684 |
100,278 |
* Analysis by date of onset, except for hepatitis B and hepatitis C unspecified, where analysis is by report date. Date of onset is a composite of three components: (i) the true onset date from a clinician, if available, (ii) the date the laboratory test was ordered, or (iii) the date reported to NNDSS.
†Unspecified hepatitis includes cases with hepatitis in whom the duration of illness cannot be determined.
‡ The analysis was performed by report date.
§ Includes hepatitis C incident in Northern Territory and Queensland.
║ Notified as 'foodborne disease' or 'gastroenteritis in an institution' in New South Wales.
¶ Infections with Shiga-like toxin (verotoxin) producing E. coli. (SLTEC/VTEC).
** Northern Territory, Queensland, South Australia, Victoria and Western Australia: includes gonococcal neonatal ophthalmia.
††Includes 14 cases of congenital syphilis, one from New South Wales and 13 from the Northern Territory.
‡‡ Includes congenital rubella.
NN Not notifiable.
NEC Not elsewhere classified.
Table 3. Notification rates of communicable diseases, Australia, 2002, by state and territory (per 100,000 population)
Disease |
State or territory | Aust | |||||||
|---|---|---|---|---|---|---|---|---|---|
| ACT | NSW | NT | Qld | SA | Tas | Vic | WA | ||
Bloodborne diseases |
|||||||||
| Hepatitis B (incident) | 0.0 |
1.3 |
5.1 |
1.5 |
0.7 |
4.0 |
3.6 |
1.8 |
2.0 |
| Hepatitis B (unspecified)†,‡ | 25.5 |
52.6 |
NN |
20.0 |
17.6 |
8.5 |
38.8 |
20.9 |
35.5 |
| Hepatitis C (incident) | 1.9 |
2.2 |
NN |
NN |
2.8 |
3.2 |
1.8 |
7.0 |
2.8 |
| Hepatitis C (unspecified)†,‡,§ | 70.2 |
100.5 |
97.5 |
72.8 |
42.2 |
80.6 |
84.0 |
55.7 |
81.3 |
| Hepatitis D | 0.0 |
0.2 |
0.0 |
0.0 |
0.0 |
0.0 |
0.2 |
0.0 |
0.1 |
| Hepatitis (NEC) | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Gastrointestinal diseases |
|||||||||
| Botulism | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Campylobacteriosis║ | 110.6 |
NN |
105.0 |
104.8 |
160.6 |
128.2 |
103.0 |
108.4 |
112.2 |
| Cryptosporidiosis | 11.2 |
4.6 |
109.6 |
54.7 |
8.0 |
9.9 |
6.0 |
11.2 |
16.6 |
| Haemolytic uraemic syndrome | 0.0 |
0.1 |
0.5 |
0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.1 |
| Hepatitis A | 1.2 |
2.2 |
23.7 |
1.8 |
1.0 |
0.8 |
1.5 |
1.6 |
2.0 |
| Hepatitis E | 0.3 |
0.1 |
0.0 |
0.0 |
0.0 |
0.4 |
0.0 |
0.0 |
0.1 |
| Listeriosis | 0.0 |
0.2 |
0.0 |
0.5 |
0.1 |
0.4 |
0.3 |
0.6 |
0.3 |
| Salmonellosis (NEC) | 28.6 |
30.7 |
166.7 |
72.1 |
33.2 |
34.9 |
25.7 |
36.6 |
39.4 |
| Shigellosis | 0.0 |
1.2 |
52.0 |
2.5 |
1.6 |
0.2 |
1.4 |
6.4 |
2.5 |
| SLTEC, VTEC¶ | 0.0 |
0.0 |
0.0 |
0.1 |
2.4 |
0.0 |
0.1 |
0.2 |
0.3 |
| Typhoid | 0.3 |
0.4 |
0.0 |
0.3 |
0.3 |
0.0 |
0.5 |
0.5 |
0.4 |
Quarantinable diseases |
|||||||||
| Cholera | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Plague | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Rabies | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Viral haemorrhagic fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Yellow fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Sexually transmissible diseases |
|||||||||
| Chlamydial infection(NEC) | 142.9 |
83.2 |
732.8 |
174.0 |
114.5 |
101.1 |
102.0 |
153.9 |
122.3 |
| Donovanosis | 0.0 |
0.0 |
4.5 |
0.1 |
0.0 |
0.0 |
0.0 |
0.1 |
0.1 |
| Gonococcal infection** | 4.7 |
21.1 |
772.7 |
25.2 |
12.6 |
3.0 |
16.8 |
69.6 |
31.8 |
| Syphilis†† | 3.7 |
9.4 |
209.1 |
9.2 |
2.0 |
3.4 |
0.6 |
8.4 |
8.3 |
Vaccine preventable diseases |
|||||||||
| Diphtheria | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Haemophilus influenzae type b | 0.0 |
0.2 |
1.5 |
0.2 |
0.1 |
0.0 |
0.0 |
0.3 |
0.1 |
| Invasive pneumococcal disease | 9.3 |
12.7 |
32.8 |
11.8 |
11.4 |
13.3 |
9.3 |
10.7 |
11.5 |
| Laboratory-confirmed influenza | 5.9 |
15.1 |
28.3 |
31.1 |
19.0 |
1.1 |
12.3 |
28.2 |
18.6 |
| Measles | 0.0 |
0.1 |
0.0 |
0.2 |
0.1 |
0.0 |
0.3 |
0.0 |
0.2 |
| Mumps | 0.0 |
0.4 |
0.5 |
0.2 |
0.7 |
0.0 |
0.2 |
0.7 |
0.4 |
| Pertussis | 15.5 |
28.1 |
18.7 |
50.0 |
29.8 |
8.7 |
18.1 |
10.8 |
27.4 |
| Poliomyelitis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Rubella‡‡ | 0.9 |
0.5 |
0.5 |
5.1 |
0.3 |
0.2 |
0.3 |
0.2 |
1.3 |
| Tetanus | 0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
Vectorborne diseases |
|||||||||
| Arbovirus infection NEC | 0.0 |
0.2 |
0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
| Barmah Forest virus infection | 0.0 |
5.9 |
11.6 |
10.5 |
0.2 |
0.0 |
1.2 |
1.9 |
4.6 |
| Dengue | 0.9 |
1.0 |
16.2 |
2.2 |
0.5 |
0.2 |
0.2 |
0.9 |
1.1 |
| Japanese encephalitis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Kunjin virus infection | NN |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Malaria | 4.0 |
1.6 |
12.1 |
5.5 |
0.9 |
3.4 |
1.3 |
1.3 |
2.4 |
| Murray Valley encephalitis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
| Ross River virus infection | 0.0 |
2.7 |
31.8 |
23.9 |
2.7 |
24.8 |
0.8 |
6.4 |
7.4 |
Zoonoses |
|||||||||
| Anthrax | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Australian bat lyssavirus | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Brucellosis | 0.0 |
0.0 |
0.0 |
0.9 |
0.0 |
0.0 |
0.0 |
0.1 |
0.2 |
| Leptospirosis | 0.0 |
0.5 |
1.5 |
2.5 |
0.1 |
0.4 |
0.4 |
0.2 |
0.8 |
| Ornithosis | 0.0 |
2.2 |
1.0 |
0.1 |
0.2 |
0.2 |
0.9 |
0.3 |
1.0 |
| Other lyssavirus (NEC) | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Q fever | 0.0 |
4.4 |
0.5 |
9.1 |
1.8 |
0.0 |
1.7 |
1.0 |
3.9 |
Other bacterial infections |
|||||||||
| Invasive meningococcal infection | 1.9 |
3.2 |
4.5 |
3.3 |
2.0 |
5.5 |
4.3 |
3.4 |
3.5 |
| Legionellosis | 0.9 |
0.6 |
0.5 |
1.2 |
4.3 |
0.0 |
2.2 |
2.9 |
1.6 |
| Leprosy | 0.0 |
0.0 |
0.5 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
| Tuberculosis | 4.7 |
6.5 |
19.2 |
3.3 |
2.6 |
2.1 |
5.5 |
2.5 |
5.0 |
* Analysis by date of onset, except for hepatitis B and hepatitis C unspecified, where analysis is by report date. Date of onset is a composite of three components: (i) the true onset date from a clinician, if available, (ii) the date the laboratory test was ordered, or (iii) the date reported to NNDSS.
†Unspecified hepatitis includes cases with hepatitis in whom the duration of illness cannot be determined.
‡ The analysis was performed by report date.
§ Includes hepatitis C incident in Northern Territory and Queensland.
║ Notified as 'foodborne disease' or 'gastroenteritis in an institution' in New South Wales.
¶ Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (SLTEC/VTEC).
** Northern Territory, Queensland, South Australia, Victoria and Western Australia: includes gonococcal neonatal ophthalmia.
††Includes 14 cases of congenital syphilis, one from New South Wales and 13 from the Northern Territory.
‡‡ Includes congenital rubella.
NN Not notifiable.
NEC Not elsewhere classified.
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 28 No 1, March 2004
NNDSS Annual report 2003
Communicable Diseases Intelligence